With growing investments, 2025 looks promising for the femtech sector
October marked Breast Cancer Awareness Month, focused on awareness, early detection, and research funding.
Women’s health, historically neglected, is now a key focus for startups and private equity firms. Female health providers are leveraging telemedicine and AI to address market needs from puberty to postmenopause.
In 2024, €339.4 million of venture capital funding was invested in 47 femtech deals, surpassing the 2021 peak of €325 million, according to Pitchbook data.
Europe’s femtech market is set to reach $35 billion by 2032, according to Sie Ventures, a venture capital firm focused on female-led businesses. Flo Health, a menstrual tracking app, raised $200 million, achieving a $1 billion valuation and becoming Europe’s first femtech unicorn. Click here to read HBI’s report on it.
The UK leads Europe in women’s health innovation, with 31.8% of startups, while France, Germany, Sweden, and Switzerland also drive investment.
What female health sectors are being addressed?
Startups are focusing on maternal health, menstrual products, gynaecology, and fertility. In recent years, women’s health startups have attracted $2.2 billion, with 60% of top deals targeting endometriosis, fertility, and maternal health.
App-based solutions for fertility tracking and period management are expanding, offering broader market potential.
Key drivers of femtech investments:
According to an LEK report, femtech investments are driven by regulatory changes, evolving investor priorities, and the increasing demand for data. Technological adoption, new business models, and improved healthcare access for women have further fueled market growth.
Outlook for 2025:
Challenges such as gender bias in funding and limited access to clinical research remain in the sector. Industry experts forecast a rise in investment and stronger public-private partnerships in 2025, driven by increasing attention to women’s health from healthcare investors. Moreover, policy shifts, including the UK’s Women’s Health Strategy and France’s focus on endometriosis, signal a growing prioritisation of women’s health. Additionally, GDPR offers a competitive advantage in data protection, further enhancing the sector’s potential.
We would welcome your thoughts on this story. Email your views to Rakshitha Narasimhan or call 0207 183 3779.
